Hanover Advisors’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$265K Buy
10,940
+442
+4% +$10.7K 0.1% 101
2026
Q1
$254K Sell
10,498
-571
-5% -$13.9K 0.1% 99
2025
Q4
$269K Buy
+11,069
New +$269K 0.1% 89

Other funds holding IBDS

Hanover Advisors's IBDS Position: Q2 2026 in Review

Hanover Advisors increased its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 4.2% in Q2 2026, buying an estimated $10.7K and bringing the position to 10,940 shares worth $265K. The position accounts for 0.1% of the portfolio, ranked #101.

Hanover Advisors first reported a position in IBDS in Q4 2025 and has held it in 3 quarters since. The position peaked at $269K in Q4 2025. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • Hanover Advisors held 10,940 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $265K as of Q2 2026.
  • Hanover Advisors bought 442 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $10.7K.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.1% of Hanover Advisors's portfolio in Q2 2026, its #101 holding.
  • Hanover Advisors first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q4 2025 and has held it in 3 quarters since.
  • Hanover Advisors's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $269K in Q4 2025.
  • 416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Hanover Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.